TRENTON, N.J. (AP) — If doctors and patients used prescription drugs more wisely, they could save the U.S.
TRENTON, N.J. (AP) — Shares of diagnostic test maker Myriad Genetics Inc.
Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of
NEW BRUNSWICK, N.J.
TRENTON, N.J. (AP) — Drugmaker Pfizer Inc.
TRENTON, N.J. (AP) — Spending on prescription medicines in the U.S.
TRENTON, N.J. (AP) — Spending on prescription medicines in the U.S.
Several Johnson & Johnson shareholders took the health care giant to task during its annual meeting Thursday, criticizing management for
TRENTON, N.J. (AP) — Pfizer Inc.
Amgen Inc.'s new CEO Robert A. Bradway, who took the helm of the biotechnology giant in May, nearly doubled his salary last year.
TRENTON, N.J. (AP) — Drugmaker Merck & Co.
Health products giant Johnson & Johnson on Monday issued yet another product recall, this one for OneTouch VerioIQ blood glucose meters sold
Johnson & Johnson is recalling all its OneTouch VerioIQ blood glucose meters in the U.S.
TRENTON, N.J. (AP) — Shares of drugmaker Amgen Inc.
More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against
Johnson & Johnson has quietly recalled some of its popular personal lubricants in order to avert potentially expensive new regulatory reviews.
TRENTON, N.J. (AP) — Hospital stays can be scary, but they don't have to be.
TRENTON, N.J. (AP) — Drugmaker Pfizer Inc.
A New Jersey jury on Thursday ordered Johnson & Johnson to pay punitive damages of $7.76 million to a former nurse who blames its vaginal mesh
A New Jersey jury on Monday awarded $3.35 million to a former nurse who blames Johnson & Johnson's vaginal mesh implant for years of severe,
TRENTON, N.J. (AP) — Shares of drugmaker Merck & Co.
GOOD START: Drugmaker Pfizer's initial public stock offering of its animal health business, Zoetis, raised $2.2 billion, the largest IPO by a U.S.
TRENTON, N.J. (AP) — In a story Jan.
Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back
Drugmaker Pfizer Inc.'s fourth-quarter results easily beat Wall Street expectations, driving up its stock, as profit more than quadrupled, due to









